Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data
- Resource Type
- Article
- Authors
- Terai, Hideki; Soejima, Kenzo; Shimokawa, Asanao; Horinouchi, Hidehito; Shimizu, Junichi; Hase, Tetsunari; Kanemaru, Ryota; Watanabe, Kana; Ninomiya, Kiichiro; Aragane, Naoko; Yanagitani, Noriko; Sakata, Yoshihiko; Seike, Masahiro; Fujimoto, Daichi; Kasajima, Masashi; Kubo, Akihito; Kusumoto, Sojiro; Oyamada, Yoshitaka; Fujiwara, Keiichi; Mori, Masahide; Hashimoto, Midori; Shingyoji, Masato; Kodani, Masahiro; Sakamoto, Jin; Agatsuma, Toshihiko; Kashiwabara, Kosuke; Inomata, Minehiko; Tachihara, Motoko; Tanaka, Kazuhisa; Hayashihara, Kenji; Koyama, Nobuyuki; Matsui, Kaoru; Minato, Koichi; Jingu, Daisuke; Sakashita, Hiroyuki; Hara, Satoshi; Naito, Tomoyuki; Okada, Asuka; Tanahashi, Masayuki; Sato, Yuki; Asano, Koichiro; Takeda, Takayuki; Nakazawa, Kensuke; Harada, Toshiyuki; Shibata, Kazuhiko; Kato, Tatsuo; Miyaoka, Etsuo; Yoshino, Ichiro; Gemma, Akihiko; Mitsudomi, Tetsuya
- Source
- In JTO Clinical and Research Reports November 2022 3(11)
- Subject
- Language
- ISSN
- 2666-3643